ProfileGDS4718 / 236312_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 61% 45% 39% 51% 49% 86% 78% 51% 43% 58% 51% 56% 70% 83% 82% 62% 58% 68% 74% 49% 55% 58% 54% 66% 65% 70% 56% 57% 53% 82% 72% 80% 39% 51% 54% 79% 87% 43% 48% 39% 46% 74% 52% 74% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.2166861
GSM549102patient 115, normal, homogenized [OPG study]5.2566945
GSM549104patient 119, normal, homogenized [OPG study]4.9552839
GSM549108patient 138, normal, homogenized [OPG study]5.6354351
GSM549119patient 077, normal, homogenized [OPG study]5.4885449
GSM549133patient 032, cancer, homogenized [OPG study]8.7580286
GSM549139patient 042, cancer, homogenized [OPG study]7.7243778
GSM549099patient 107, normal, homogenized [OPG study]5.5751551
GSM549109patient 139, normal, homogenized [OPG study]5.1591443
GSM549110patient 046, normal, homogenized [OPG study]6.0044658
GSM549114patient 063, normal, homogenized [OPG study]5.5354251
GSM549122patient 082, normal, homogenized [OPG study]5.8711156
GSM549134patient 033, cancer, homogenized [OPG study]6.8819370
GSM549136patient 036, cancer, homogenized [OPG study]8.2728783
GSM549140patient 044, cancer, homogenized [OPG study]8.1958882
GSM549111patient 047, normal, homogenized [OPG study]6.2719862
GSM549113patient 057, normal, homogenized [OPG study]5.9551558
GSM549132patient 031, cancer, homogenized [OPG study]6.7031168
GSM549137patient 038, cancer, homogenized [OPG study]7.2388574
GSM549142patient 047, cancer, homogenized [OPG study]5.5869949
GSM549100patient 110, normal, homogenized [OPG study]5.8305455
GSM549107patient 135, normal, homogenized [OPG study]5.9847758
GSM549115patient 068, normal, homogenized [OPG study]5.724954
GSM549116patient 072, normal, homogenized [OPG study]6.5510266
GSM549120patient 078, normal, homogenized [OPG study]6.4757665
GSM549131patient 030, cancer, homogenized [OPG study]6.9291570
GSM549118patient 074, normal, homogenized [OPG study]5.8759256
GSM549129patient 027, cancer, homogenized [OPG study]5.9603357
GSM549123patient 088, normal, homogenized [OPG study]5.7009753
GSM549124patient 006, cancer, homogenized [OPG study]7.9997882
GSM549126patient 015, cancer, homogenized [OPG study]7.0683572
GSM549128patient 025, cancer, homogenized [OPG study]7.9265780
GSM549103patient 117, normal, homogenized [OPG study]4.986539
GSM549117patient 073, normal, homogenized [OPG study]5.5027651
GSM549138patient 041, cancer, homogenized [OPG study]5.729354
GSM549141patient 045, cancer, homogenized [OPG study]7.8649579
GSM549130patient 028, cancer, homogenized [OPG study]8.5964487
GSM549101patient 111, normal, homogenized [OPG study]5.1523143
GSM549105patient 128, normal, homogenized [OPG study]5.4455948
GSM549106patient 134, normal, homogenized [OPG study]4.9190239
GSM549112patient 048, normal, homogenized [OPG study]5.2701946
GSM549125patient 011, cancer, homogenized [OPG study]7.1832974
GSM549127patient 024, cancer, homogenized [OPG study]5.6742352
GSM549135patient 035, cancer, homogenized [OPG study]7.3262274